In a new study, the RSV drug nirsevimab was 93% effective at preventing young children from being hospitalized for the ...
Enanta Pharmaceuticals’ respiratory syncytial virus (RSV) antiviral reduced the viral load in a phase 2 study in children, ...
Just over a fifth of US adults aged 60 and older had been vaccinated against RSV as of March 2024, with disparities seen by ...
RSV prevention among children, including nirsevimab and the maternal RSVpreF vaccine, may be associated with a reduction in pediatric ICU utilization.
While RSV is not on the CDC’s current list of Nationally Notifiable Diseases like COVID and influenza, a new rule from the ...
The health service's vaccination scheme will also include a rollout of flu and Covid-19 vaccines. 'Vitally important' Dr ...
Doctors in the DMV are seeing more children and seniors coming down with respiratory illnesses like RSV which can be ...
Roy Buchanan, an analyst from JMP Securities, reiterated the Buy rating on Enanta Pharmaceuticals (ENTA – Research Report). The associated ...
The latest announcement is out from Enanta Pharmaceuticals ( (ENTA) ).
Enanta Pharmaceuticals said it saw positive results from its recent study evaluating a treatment for respiratory syncytial virus in newborns, also known as RSV.
While cold and flu symptoms may be similar, the flu tends to be more severe, with symptoms coming on suddenly, according to ...
C Midwest Express Clinic. RSV is a highly contagious virus that infects the lungs and airways. Read on to learn more about ...